Yahoo
LSE - Delayed Quote GBp

Diaceutics PLC (DXRX.L)

195.60 -4.90 (-2.44%)
As of 3:08:14 PM GMT. Market Open.
View in AlphaSpace Currency in GBP All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
41,329 38,437 32,158 23,699 19,504
Cost of Revenue
-7,076 -6,958 -3,888 -3,993 -2,763
Gross Profit
34,253 31,479 28,270 19,706 16,741
Selling, General and Administrative Expenses
-35,197 -31,691 -30,742 -22,784 -16,280
Other Income/Expense, Operating
150 255 17 60 114
Operating Income/Expenses
-35,047 -31,436 -30,725 -22,724 -16,166
Total Operating Profit/Loss
-794 43 -2,455 -3,018 575
Total Net Finance Income/Expense
141 259 547 580 -11
Non-Operating Income/Expenses, Total
141 259 547 580 -11
Pretax Income
-653 302 -1,908 -2,438 564
Provision for Income Tax
382 -205 205 692 160
Net Income from Continuing Operations
-271 97 -1,703 -1,746 724
Net Income after Extraordinary Items and Discontinued Operations
-271 97 -1,703 -1,746 724
Net Income after Non-Controlling/Minority Interests
-271 97 -1,703 -1,746 724
Net Income Available to Common Stockholders
-271 97 -1,703 -1,746 724
Diluted Net Income Available to Common Stockholders
-271 97 -1,703 -1,746 724
Basic EPS
-0.00 0.00 -0.02 -0.02 0.01
Diluted EPS
-0.00 0.00 -0.02 -0.02 0.01
Basic Weighted Average Shares Outstanding
84,900.94 84,834.34 84,453.53 84,226.82 84,149.60
Diluted Weighted Average Shares Outstanding
85,192.26 85,125.65 84,453.53 84,226.82 86,089.52
Income Statement, Supplemental
EBIT
-794 43 -2,455 -3,018 573
EBITDA
5,675 5,855 2,172 1,602 3,424
Normalized EBITDA
8,572 7,573 4,206 2,802 3,583
Normalized Income
791.75 787 -698.87 -1,425.16 1,158.16
Total Unusual Items
1,417 920 1,125 448 536
Total Unusual Items Excluding Goodwill
1,417 920 1,125 448 536
Tax Effect of Unusual Items
354.25 230 120.87 127.16 101.84
Tax Rate, Calculated
0.25 0.25 0.11 0.28 0.19
12/31/2022 - 3/21/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: